Michihiro Fujiwara Selected Research

Michihiro Fujiwara Research Topics

Disease

31	Brain Ischemia (Cerebral Ischemia) 03/2013 - 01/2003
19	Ischemia 12/2012 - 12/2002
13	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 12/2002
10	Infarction (Infarctions) 12/2012 - 10/2004
9	Dementia (Dementias) 03/2014 - 10/2003
9	Cerebral Infarction 09/2009 - 01/2003
7	Hypoxia (Hypoxemia) 11/2005 - 10/2002
6	Memory Disorders (Memory Loss) 08/2012 - 01/2006
6	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2012 - 12/2002
5	Amyloid Plaque 03/2013 - 05/2005
5	Stroke (Strokes) 12/2012 - 04/2006
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2012 - 12/2003
5	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 09/2008 - 10/2005
4	Brain Injuries (Brain Injury) 10/2012 - 03/2008
3	Inflammation (Inflammations) 10/2012 - 10/2004
3	Hypothermia 01/2008 - 05/2004
3	Catalepsy 01/2008 - 11/2006
3	Tremor (Tremors) 01/2008 - 01/2006
2	Transient Ischemic Attack 07/2013 - 03/2013
2	Hypertension (High Blood Pressure) 01/2012 - 09/2010
2	Cognitive Dysfunction 02/2008 - 01/2006
1	Blister (Bulla) 05/2015
1	Intracranial Vasospasm 12/2014
1	Fibrosis (Cirrhosis) 10/2013
1	Myocardial Infarction 10/2013
1	Encephalitis (Encephalitis, Rasmussen) 10/2012
1	Asthma (Bronchial Asthma) 02/2012
1	Immune System Diseases (Immune Disorders) 02/2012
1	Myocarditis (Carditis) 11/2010
1	Ischemic Stroke 07/2010
1	Depressive Disorder (Melancholia) 05/2010
1	Colorectal Neoplasms (Colorectal Cancer) 03/2010
1	Thrombosis (Thrombus) 02/2010
1	Substance-Related Disorders (Drug Abuse) 12/2009
1	Deafness (Deaf Mutism) 06/2009

Drug/Important Bio-Agent (IBA)

9	Neuroprotective AgentsIBA 01/2011 - 10/2003
9	Dronabinol (THC)FDA LinkGeneric 02/2008 - 10/2004
8	Pharmaceutical PreparationsIBA 01/2011 - 03/2005
8	CannabidiolIBA 07/2010 - 10/2004
7	Amyloid beta-PeptidesIBA 07/2013 - 12/2002
6	Cholinergic Agents (Cholinergics)IBA 07/2013 - 02/2007
6	HMGB1 Protein (HMG1)IBA 10/2012 - 03/2008
6	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2009 - 12/2002
5	Yi-Gan SanIBA 03/2014 - 03/2009
4	Glutamic Acid (Glutamate)FDA Link 04/2010 - 04/2004
3	Amyloid (Amyloid Fibrils)IBA 03/2013 - 12/2003
3	Telmisartan (Micardis)FDA Link 01/2012 - 10/2009
3	Donepezil (Aricept)FDA LinkGeneric 01/2011 - 06/2004
3	5-HT1A Serotonin ReceptorIBA 09/2008 - 10/2005
3	Scopolamine (Hyoscine)FDA Link 01/2008 - 01/2005
3	OxotremorineIBA 01/2008 - 01/2006
3	theanineIBA 01/2008 - 06/2004
2	salicylhydroxamic acid (SHAM)IBA 12/2014 - 03/2013
2	Dynamin IIBA 07/2013 - 07/2010
2	Protein Isoforms (Isoforms)IBA 12/2012 - 01/2003
2	Peroxidase (Myeloperoxidase)IBA 10/2012 - 12/2008
2	von Willebrand FactorIBA 10/2012 - 02/2010
2	GangliosidesIBA 02/2012 - 02/2003
2	Type 1 Angiotensin ReceptorIBA 01/2012 - 09/2010
2	PPAR gammaIBA 09/2010 - 10/2009
2	Proteins (Proteins, Gene)FDA Link 07/2010 - 12/2003
2	SynaptophysinIBA 07/2010 - 04/2010
2	Kangen-karyuIBA 04/2010 - 03/2009
2	Olanzapine (Zyprexa)FDA Link 09/2008 - 02/2008
2	Antipsychotic Agents (Antipsychotics)IBA 09/2008 - 10/2005
2	Haloperidol (Haldol)FDA LinkGeneric 02/2008 - 10/2005
2	nilvadipine (Escor)IBA 04/2007 - 10/2003
2	Amlodipine (Norvasc)FDA LinkGeneric 04/2007 - 10/2003
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 03/2007 - 10/2004
2	AMPA Receptors (AMPA Receptor)IBA 01/2007 - 01/2005
2	TAK 147IBA 08/2005 - 06/2004
2	LipopolysaccharidesIBA 03/2005 - 12/2004
2	EnzymesIBA 10/2004 - 12/2002
2	N-Methylaspartate (NMDA)IBA 01/2004 - 12/2002
1	Peptides (Polypeptides)IBA 01/2016
1	TubulinIBA 05/2015
1	SEA 0400IBA 12/2012
1	2- (2- (4- (4- nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonateIBA 12/2012
1	Glycoproteins (Glycoprotein)IBA 10/2012
1	Nuclear Proteins (Protein, Nuclear)IBA 10/2012
1	haematoside synthetaseIBA 02/2012
1	Serotonin ReceptorsIBA 04/2011
1	PropaneIBA 04/2011
1	Anti-Anxiety Agents (Anxiolytics)IBA 04/2011
1	Cytidine Diphosphate Choline (Citicoline)IBA 01/2011
1	Cardiac MyosinsIBA 11/2010
1	R-SNARE Proteins (Vesicle-Associated Membrane Protein)IBA 07/2010
1	Testosterone (Sustanon)FDA Link 05/2010
1	fluorocitrateIBA 04/2010
1	Kainic Acid (Kainate)IBA 04/2010
1	Bevacizumab (Avastin)FDA Link 03/2010
1	Platelet Membrane GlycoproteinsIBA 02/2010
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 09/2009
1	G(M3) GangliosideIBA 06/2009

Therapy/Procedure

2	Oral Administration 01/2012 - 04/2010
2	Therapeutics 03/2005 - 10/2004
1	Transplantation 10/2013
1	Homologous Transplantation 10/2013
1	Cognitive Training 12/2010
1	Lasers (Laser) 03/2009